+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Spatial Genomics & Transcriptomics Market by Product, Technology, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6012040
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Spatial Genomics & Transcriptomics Market grew from USD 782.33 million in 2023 to USD 879.03 million in 2024. It is expected to continue growing at a CAGR of 13.62%, reaching USD 1.91 billion by 2030.

Spatial genomics and transcriptomics involve the analysis of gene expression and genetic material within the spatial organization of cells in tissue samples, providing an unprecedented understanding of biological systems in situ. The necessity of these technologies is underscored by their ability to reveal complex tissue architecture and cellular interactions, pivotal for advancements in areas like cancer research, neuroscience, and developmental biology. Applications span across drug discovery, personalized medicine, and biomarker identification, making them highly sought-after in pharmaceutical and biotechnology sectors. End-users include academic and research institutions, clinical research organizations, and hospitals, highlighting a broad end-use scope.

The market is primarily driven by technological advancements, increasing investments in R&D, and a growing interest in precision medicine. The advent of innovative platforms and the integration of AI for data analysis present key growth opportunities. Recommendations for grasping these opportunities include investing in scalable technology platforms, forming strategic partnerships with healthcare providers, and focusing on training for skilled personnel. On the flip side, the market faces challenges such as high costs, data analysis complexity, and the need for significant specialized expertise, which could potentially hinder widespread adoption.

Limitations also include ethical concerns surrounding genetic data and limited standardization across technologies. Despite these challenges, there is significant room for innovation, particularly in developing cost-effective solutions, enhancing data visualization tools, and creating more user-friendly interfaces that simplify complex data interpretation. Companies could focus on cross-disciplinary collaborations to foster innovations that address real-world biological questions. Overall, the spatial genomics and transcriptomics market is dynamic, presenting both substantial growth prospects and critical challenges, necessitating a nuanced approach to capture its full potential and drive meaningful advancements in the life sciences.

Understanding Market Dynamics in the Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of chronic diseases and need for designing accurate and effective drugs
    • Improving regulatory and ethical acceptance of genomics and sequencing technologies
    • Emerging use of spatial analysis to advance precision medicine & diagnostics
  • Market Restraints
    • Limited awareness among healthcare professionals about genomic medicine in developing economies
  • Market Opportunities
    • Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
    • Rising public and private funding for genomics & transcriptomics research
  • Market Challenges
    • Reimbursement inconsistency and uncertainty in gene & single-cell sequencing

Exploring Porter’s Five Forces for the Spatial Genomics & Transcriptomics Market

Porter’s Five Forces framework further strengthens the insights of the Spatial Genomics & Transcriptomics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Spatial Genomics & Transcriptomics Market

External macro-environmental factors deeply influence the performance of the Spatial Genomics & Transcriptomics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
    • Instruments
    • Software
  • Technology
    • Immunohistochemistry Screening
    • Spatial Genomics
      • Biochemical Techniques
      • Fluorescence in Situ Hybridization
      • Genome Perturbation Tools
      • Massively-Parallel Sequencing
      • Microscopy-Based Live DNA Imaging
    • Spatial Transcriptomics
      • In Situ Sequencing
      • Microtomy Sequencing
      • Sequencing-Based Methods
      • Transcriptome In-vivo Analysis
  • End-Use
    • Academic Institutes
    • Diagnostic Institutes
    • Pharmaceutical Manufacturer
    • Translational Research
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and need for designing accurate and effective drugs
5.1.1.2. Improving regulatory and ethical acceptance of genomics and sequencing technologies
5.1.1.3. Emerging use of spatial analysis to advance precision medicine & diagnostics
5.1.2. Restraints
5.1.2.1. Limited awareness among healthcare professionals about genomic medicine in developing economies
5.1.3. Opportunities
5.1.3.1. Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
5.1.3.2. Rising public and private funding for genomics & transcriptomics research
5.1.4. Challenges
5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Spatial Genomics & Transcriptomics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Software
7. Spatial Genomics & Transcriptomics Market, by Technology
7.1. Introduction
7.2. Immunohistochemistry Screening
7.3. Spatial Genomics
7.3.1. Biochemical Techniques
7.3.2. Fluorescence in Situ Hybridization
7.3.3. Genome Perturbation Tools
7.3.4. Massively-Parallel Sequencing
7.3.5. Microscopy-Based Live DNA Imaging
7.4. Spatial Transcriptomics
7.4.1. In Situ Sequencing
7.4.2. Microtomy Sequencing
7.4.3. Sequencing-Based Methods
7.4.4. Transcriptome In-vivo Analysis
8. Spatial Genomics & Transcriptomics Market, by End-Use
8.1. Introduction
8.2. Academic Institutes
8.3. Diagnostic Institutes
8.4. Pharmaceutical Manufacturer
8.5. Translational Research
9. Americas Spatial Genomics & Transcriptomics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Spatial Genomics & Transcriptomics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. OmicsVeu Launches An Extensive Line Of Spatial Biology
12.3.2. Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
12.3.3. Lexogen Introduces CORALL RNA-Seq V2 - a fast and flexible whole transcriptome RNA-Seq Library Prep Kit.
12.3.4. NanoString Launches New nCounter Pro Analysis System
12.3.5. Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
12.3.6. Fulgent Genetics Announces Strategic Investment in Spatial Genomics
12.3.7. Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
12.3.8. Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
12.3.9. Andor and Akoya Biosciences to Collaborate in Spatial Omics market
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOCHEMICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOME PERTURBATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MASSIVELY-PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPY-BASED LIVE DNA IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROTOMY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING-BASED METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSCRIPTOME IN-VIVO ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DIAGNOSTIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 50. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 51. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 77. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 78. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 82. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 83. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 92. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 93. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 122. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 123. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 138. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 139. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 143. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 144. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 148. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 153. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 168. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 169. ITALY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 183. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 184. NORWAY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 188. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 189. POLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 190. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 193. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 194. QATAR SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 213. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 214. SPAIN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 240. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Spatial Genomics & Transcriptomics market, which are profiled in this report, include:
  • 10X Genomics, Inc.
  • Akoya Biosciences, Inc.
  • Arima Genomics, Inc.
  • AtlasXomics Inc.
  • Axcelead Drug Discovery Partners Inc.
  • BGI Australia
  • Bio-Techne Corporation
  • BioSpyder Technologies Inc.
  • Bruker Corporation
  • Bucher Biotec AG
  • CD Genomics
  • CeGaT GmbH
  • Dovetail Genomics, LLC
  • Easi-Genomics
  • Enzo Life Sciences, Inc.
  • Eurofins Genomics
  • Fulgent Genetics
  • Genomic Vision SA
  • Illumina, Inc.
  • Indivumed Group
  • Ionpath, Inc.
  • Lunaphore Technologies S.A.
  • Miltenyi Biotec
  • Nanostring Technologies, Inc.
  • Natera Inc.
  • Novogene Co, Ltd.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • PT Pandu Biosains
  • Rarecyte, Inc
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Single Cell Discoveries
  • Single Technologies AB
  • Singular Genomics System, Inc.
  • Spatial Genomics
  • Springer Nature
  • Standard BioTools Inc.
  • Tecan Group Ltd.
  • Ultivue, Inc.
  • Veracyte, Inc.
  • Veranome Biosystems, LLC
  • Vizgen Corporation

Methodology

Loading
LOADING...

Table Information